Showing results (441-450 of 10,064) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|October 28, 2014
Oxytocin - a multifunctional analgesic for chronic deep tissue painBurel R Goodin, Timothy J Ness, Meredith T RobbinsCurrent Pharmaceutical Design|September 2, 2014
Genetic aspects of lone atrial fibrillation: what do we know?Laura Andreasen, Jonas B Nielsen, Morten S OlesenCurrent Pharmaceutical Design|September 2, 2014
Biomarkers in lone atrial fibrillation - an additional 'fine tuning' of risk?Darae Ko, Jared W Magnani, Elaine M HylekCurrent Pharmaceutical Design|September 2, 2014
Best practice for atrial fibrillation patient educationDeirdre A Lane, Rachel V Barker, Gregory Y H LipCurrent Pharmaceutical Design|August 29, 2014
Genetic signatures in the treatment of strokeAnjana Munshi, Vandana SharmaCurrent Pharmaceutical Design|August 29, 2014
Are patient self-report questionnaires as "scientific" as biomarkers in "treat-to-target" and prognosis in rheumatoid arthritis?Theodore Pincus, Isabel CastrejónCurrent Pharmaceutical Design|August 29, 2014
Predicting toxicity: biomarkers and the value of the patient's opinionMj Garcia de Yebenes, E Loza, L CarmonaCurrent Pharmaceutical Design|August 29, 2014
Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular diseaseLuis Rodriguez-Rodriguez, Raquel López-Mejias, Benjamín Fernández-Gutiérrez, et al.Current Pharmaceutical Design|August 29, 2014
Biomarkers for radiographic progression in rheumatoid arthritisA Krabben, T W J Huizinga, A H M van der Helm-van MilCurrent Pharmaceutical Design|August 29, 2014
Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatmentErik LubbertsPageof 1,007